CD8A and B-cell chronic lymphocytic leukemia: No significant differences were observed in the total levels of CD8+ T cells, except for higher levels in Basal sample among treated CLL participants compared to those in the W&W strategy (1.6-fold; p=0.0165), and higher levels in Sample 3 in the treated CLL cohort compared to healthy donors (1.5-fold; p=0.0334) (Figure 4B).